Stay updated with breaking news from Oint Inflammation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Treatment with a JAK inhibitor was found to alleviate symptoms in the small study of patients with disabling pansclerotic morphea, a rare, severe inflammatory skin disorder, first described in 1923.
The European Commission has approved the first interleukin-17A inhibitor for treating hidradenitis suppurativa.
Musculoskeletal symptoms identified in some patients treated with dupilumab for atopic dermatitis could help further understanding of how enthesitis develops.
Race does not predict osteoporosis risk, researchers found, as clinicians noted that many people with osteoporosis go unidentified.
The drug will be commercially available on July 1, 2023.